Moreover, tumor-derived CCL2, CCL12, CXCL5, S100A8, and S100A9 promote the recruitment of immature myeloid cells to the tumor stroma, facilitating the enrichment of both MDSC subpopulations within the TME [49,77,78,79]. Here, CXCL5 is linked to neoplasm.